Academia
Generally speaking, the larger the animal, the more cells they have, the more likely they are to get cancer. The longer an animal lives, even if that animal is a human being, the higher the likelihood of cancer. Except elephants. Elephants rarely get cancer.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Cryo-electron microscopy, called Cryo-EM, has been around for a while. The first model using it was deposited with the PDB (Protein Data Bank) in 1997, and the number of images has grown since.
Although the overall stock market has been a bit jittery as the result of a trade war, biotech stocks have been surprisingly steady—at least in comparison to their usual volatility.
Although the biopharma industry is churning out failure after failure of Alzheimer’s drugs, the start of the Alzheimer’s Association International Conference (AAIC) being held in Chicago this week is being met with optimism.
Last year, Novartis’ multiple sclerosis drug Gilenya generated more than $3 billion in revenue, with a little more than half of that coming from sales in the United States. As the drug faces patent loss in the future, Novartis is fighting to preserve that revenue driver with multiple lawsuits.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Recent studies in early diagnostics underline just how much focus medical technology companies are making on developing different modalities for very early cancer diagnosis. Here are just some recent examples.
Absence epilepsy is the most common type of seizure disorder in children and is the focus of a new neurology study at Baylor College of Medicine and published in the journal Nature Communications.
PRESS RELEASES